Products for transfection and reprogramming
The present invention relates in part to methods for producing tissue-specific cells from patient samples, and to tissue-specific cells produced using these methods. Methods for reprogramming cells using RNA are disclosed. Therapeutics comprising cells produced using these methods are also disclosed.
1. A cell-culture medium comprising: DMEM/F12, 10 μg/mL insulin, 5.5 μg/mL transferrin, 6.7 ng/mL sodium selenite, 20 ng/mL bFGF, and 5 mg/mL albumin, wherein the albumin is treated with an ion-exchange resin and/or charcoal.
2. The cell-culture medium of claim 1 , further comprising at least one of: 15 mM HEPES, 2 mM L-alanyl-L-glutamine, 2 μg/mL ethanolamine, 4.5 μg/mL cholesterol, 25 μg/mL polyoxyethylenesorbitan monooleate, 2 μg/mL D-alpha-tocopherol acetate, and 1 μg/mL L-ascorbic acid 2-phosphate sequimagnesium salt hydrate.
3. The cell-culture medium of claim 1 , wherein the albumin is treated with sodium octanoate.
4. The cell-culture medium of claim 1 , wherein the albumin is brought to a temperature of at least 40° C.
5. The cell-culture medium of claim 1 , wherein the albumin is recombinant.
6. A cell-culture medium comprising: DMEM/F12, 10 μg/mL insulin, 5.5 μg/mL transferrin, 6.7 ng/mL sodium selenite, 20 ng/mL bFGF, and 5 mg/mL albumin, wherein less than 0.65% of the albumin's dry weight comprises lipids and/or less than 0.35% of the albumin's dry weight comprises free fatty acids.
7. The cell-culture medium of claim 6 , further comprising at least one of: 15 mM HEPES, 2 mM L-alanyl-L-glutamine, 2 μg/mL ethanolamine, 4.5 μg/mL cholesterol, 25 μg/mL polyoxyethylenesorbitan monooleate, 2 μg/mL D-alpha-tocopherol acetate, and 1 μg/mL L-ascorbic acid 2-phosphate sequimagnesium salt hydrate.
8. The cell-culture medium of claim 6 , wherein the albumin is recombinant.
9. A kit comprising the cell-culture medium of claim 1 .
10. The kit of claim 9 , wherein the albumin is recombinant.
11. The kit of claim 9 , further comprising one or more synthetic RNA molecules, wherein the one or more synthetic RNA molecules comprise at least one RNA molecule encoding one or more reprogramming factors.
12. The kit of claim 11 , wherein the one or more synthetic RNA molecules comprise at least one RNA molecule encoding at least one of: Oct4 protein, Sox2 protein, Klf4 protein, and c-Myc protein.
13. The kit of claim 11 , wherein the one or more synthetic RNA molecules comprise at least one RNA molecule encoding Oct4 protein, at least one RNA molecule encoding Sox2 protein, at least one RNA molecule encoding Klf4 protein, and at least one molecule encoding c-Myc protein.
14. The kit of claim 11 , wherein the one or more synthetic RNA molecules comprise at least one of: a pseudouridine residue and a 5-methylcytidine residue.